跳至主要内容
临床试验/CTRI/2020/10/028476
CTRI/2020/10/028476招募中1 期

A prospective study to assess the effect ofperi operative administration of oral Resveratrol andcopper(R- Cu) on survival inGlioblastoma (GBM) patients.

Tata Memorial Centre TMC0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Radiologic suspicion of GBM on MRI brain (As per discussion in the Tumor Board meetings)
  • 2.Adults - Age above 18 years
  • 3. KPS > 70
  • 4.Planned for Debulking Surgery and adjuvant treatment at Tata memorial centre
  • 5.Adequate hepatic, renal, and hematologic function at baseline
  • 6.Patients who have given written informed consent

排除标准

  • Multifocal disease / disease not amenable to complete resection
  • 2.Any prior treatment for cancer â?? surgery, chemotherapy or radiotherapy
  • 3.Past history of cancer
  • 4.Uncontrolled medical comorbidities like hypertensive, diabetes mellitus
  • 5.Seropositivity: HbsAg, HCV, HIV positive, etc.
  • 6.Presence of metastases
  • 7.Patients taking alternative/ complementary treatments

研究者

发起方
Tata Memorial Centre TMC

相似试验